CHCL mentioned in "Wall Street Journal"...
This item copied from post on Raging Bull, about "Wall Street Journal" article on China's interest/plans re genetic engineering. Apparently CHCL (China Continental) is the ONLY company mentioned BY NAME in this story. May not be a biggie, but a mention in the Journal certainly can't hurt...
=================
CHCL IN THE WALL STREET JOURNAL TODAY
HONG KONG, March 29, 2000 -- China Continental, Inc. (OTC Bulletin Board: CHCL) was discussed in The Wall Street Journal today in the International section on page A17. The article is titled "China Bets Farm on Promise (and Glory) of Genetic Engineering" with the subtitle "Large Population Needs Food Sources: Research Stressed."
The paragraph in which China Continental, Inc. is mentioned is as follows:
Across China, debate about the safety of the technology is muted and consumer warnings almost nonexistent. Instead, the double helix of DNA has become a national symbol of progress, displayed on floats during last year's National Day parade and turned into giant sculptures in public parks. Such is Beijing's excitement that it has even set aside its traditional suspicion of foreign ownership and handed the largest chunk of Chinese land since 1949 to a U.S.-listed company, China Continental, Inc., in exchange for a promise to build a state-of-the-art genetic-research lab in Inner Mongolia.
About China Continental Inc.
China Continental, Inc., traded on the OTC Bulletin Board market since 1995, is a holding company with over ten years of experience in developing turnkey businesses. Core activities include supplying manufacturing technology on a turnkey basis, high technology manufacturing techniques in primary industries, and developing and providing technologies in agricultural genetics and farming. The Company?s agricultural genetics and farming activities are centralized in the Inner Mongolia Province of China, covering an area of 406 square kilometers to commercialize its genetic techniques in breeding as well as propagating superior livestock and products in its own Research and Development Institute.
Investor Relations Contact:
Harvey A. Goralnick
FOCUS Partners LLC
212-752-9445
chcl@focuspartners.com |
